Next Article in Journal
Erica spiculifolia Extract Potentiates Cisplatin Cytotoxicity by Reactivating p53 and Caspase-3-Dependent Apoptosis in Colorectal Carcinoma
Previous Article in Journal
Enhanced Adsorption of Xylenol Orange by CTAB-Functionalized Tomato-Derived Biochar: Mechanisms and Performance Evaluation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Eco-Friendly Synthesis of 2-Styryl-benzo[d][1,3]oxazin-4-ones from N-Cinnamoyl-Anthranilic Acids

Department of Chemical Science, University of Napoli Federico II, Via Cinthia 4, 80126 Napoli, Italy
*
Author to whom correspondence should be addressed.
Molecules 2026, 31(4), 709; https://doi.org/10.3390/molecules31040709
Submission received: 28 January 2026 / Revised: 10 February 2026 / Accepted: 11 February 2026 / Published: 18 February 2026

Abstract

N-cinnamoyl anthranilic acids are synthesized in a single, eco-friendly step by condensing various cinnamic acids with free 2-aminobenzoic acid derivatives using the mixed carbonic anhydride method. Subsequently, converting the resulting N-cinnamoyl anthranilic acids into their corresponding mixed carbonic anhydrides rapidly and efficiently affords 2-styryl-benzo[d][1,3]oxazin-4-ones. The method employs green solvents, such as acetone and 2-methyltetrahydrofuran; does not require metal catalysts or reflux conditions; and yields the desired final products without chromatographic purification.

Graphical Abstract

1. Introduction

The 4H-benzo[d][1,3]oxazin-4-one scaffold is a highly versatile and essential heterocyclic system in organic and medicinal chemistry [1,2,3]. This fused bicyclic framework—featured in several natural and bioactive compounds, including cetilistat, an anti-obesity drug [4]—contains a 1,3-oxazine ring fused to a benzene ring and has attracted sustained scientific interest due to its broad range of applications [5].
These include its use as a key synthetic intermediate and as a core pharmacophore in biologically active molecules (Figure 1). The importance of the benzo[1,3]oxazin-4-one core is twofold. First, it serves as a crucial starting point for the synthesis of numerous nitrogen-containing heterocycles. Its reactivity—driven by ring strain and the electrophilic nature of carbonyl carbon—enables facile ring-opening reactions with various nucleophiles, particularly amines [6].
This transformation efficiently provides 2-aminobenzamide derivatives, which are essential precursors for the synthesis of several medicinally relevant scaffolds, including quinazolinones, quinazolines, and benzodiazepines. Notably, this synthetic pathway is fundamental for the preparation of several blockbuster anticancer agents [7].
Beyond its role as a synthetic building block, the benzo[1,3]oxazin-4-one framework—especially when functionalized at C2—can undergo further modification via C-H activation at the 2-position [8,9]. Derivatives of this kind have demonstrated antimicrobial, anticancer, anti-inflammatory, and antiviral properties, making them attractive candidates in drug discovery [10]. 2-Styryl-substituted benzoxazinones have emerged as a promising new scaffold for rhomboid protease inhibitors [11].
Given this broad utility, the development of efficient, scalable synthetic methods for constructing the 4H-benzo[d][1,3] oxazin-4-one scaffold remains critically important.
Nonetheless, current research continues to investigate innovative approaches—such as solid-phase synthesis, microwave-assisted protocols, and sustainable catalytic systems—to improve yields, reduce reaction times, and enhance functional-group tolerance [12].
Recently, 2-substituted-4H-benzo[d][1,3]oxazin-4-ones have been synthesized from substituted anthranilic acids through decarboxylative coupling with α-ketoacids, catalyzed by cuprous salts [13]. These processes are typically carried out in DMF, require prolonged heating at 55 °C, and necessitate chromatographic purification. Alternatively, condensation between ortho-ester and substituted anthranilic acids under thermal or microwave conditions yields benzo[d][1,3]oxazin-4-ones in moderate yield, along with the corresponding 1,2-dihydro-4H-benzoxazine-4-ones [14].
An oxidative coupling between substituted anthranilic acids and isocyanides, mediated by the I2-t-butyl hydroperoxide system, affords another class of 2-aminobenzoxazin-4-ones, though typically in modest yields and highly dependent on the substitution pattern of the anthranilic region [15]. Improved results can be achieved with the addition of palladium catalysts, but at the expense of sustainability [16].
Many of these methods rely on toxic reagents and solvents, generate hazardous waste, and demand high energy input—conditions that conflict with the fundamental principles of green chemistry. As the chemical industry faces growing pressure to adopt sustainable practices, the development of environmentally benign synthetic protocols has become not merely desirable but imperative. In recent years, this challenge has stimulated extensive research focused on greening the synthesis of numerous heterocyclic systems [17].
This paper focuses specifically on new, simplified, and increasingly eco-friendly methodologies for constructing the 2-styryl-substituted 4H-benzo[d][1,3]oxazin-4-one scaffold from readily available N-cinnamoyl-anthranilic acids (Scheme 1). We evaluate green synthetic approaches as a framework for assessing the sustainability of these new protocols. By integrating this perspective with our previous experience on N-cinnamoyl anthranilic acids [18], we aim to develop a safer, cleaner, and more sustainable route to this valuable heterocycle, thereby aligning synthetic chemistry with modern eco-friendly objectives.

2. Results and Discussion

The activation and simultaneous protection of common hydroxycinnamic acids (HCAs) using the triethylamine–isobutyl chloroformate reagent system in eco-friendly solvents such as water, ethyl acetate, and acetone has enabled the development of an environmentally friendly platform for synthesizing a wide array of HCA derivatives, including amides, esters, and alcohols, several of which occur in natural products [19,20]. Coupling activated HCAs with aromatic amino acids has further enabled the development of a green synthetic route to natural avenanthramides and numerous analogues [18]. In this work, a series of N-cinnamoyl anthranilic acids was quickly prepared in acetone using the triethylamine–isobutyl chloroformate system. Coupling reactions with free amino acids cannot take place in water, the most well-known green solvent, because the aqueous phase contains large amounts of ammonium salts formed during the activation and protection of hydroxycinnamic acids [21], which prevent the existence of an unprotonated amino group. After activation and/or protection of the various cinnamic acids 1a–f at 0 °C, the reaction mixture was filtered, and the resulting filtrate was directly added to the aromatic amino acid 2a–d, along with an additional equivalent of triethylamine, as shown in Scheme 2.
The reaction mixture, stirred for 4 h at room temperature, was evaporated in vacuo, and the resulting residue was treated with anhydrous ethyl ether and stirred for an additional hour. This step ensures complete precipitation of the amide product, while unreacted starting materials remain in solution. The precipitated solid was collected by filtration and subsequently crystallized from an ethyl acetate–hexane mixture. Under these conditions, N-cinnamoyl anthranilic acids 3a–3i were obtained in 72–93% yields without the need for chromatographic purification (Scheme 2). Aromatic amino acids 2a, 2b, and 2d provided higher yields than 2c, likely due to the presence of electron-donating substituents in the para position relative to the amino group, which enhances nucleophilicity.
A representative example involving a substituted benzoic acid was also examined: conjugate coupling between 5-methoxy-2-aminobenzoic acid 2a and piperonylic acid afforded the corresponding N-piperonyl amide 3j in 79% yield (Scheme 2).
The N-cinnamoyl anthranilic acids 3c, 3f, and 3h, derived from p-coumaric, ferulic, and caffeic acids, respectively, were obtained with the phenolic groups in the cinnamic moiety protected as carbonates. In contrast, 3b and 3f were isolated with free phenolic groups in the anthranilic portion, indicating that O-acylation does not occur under these reaction conditions.
During the synthesis of N-cinnamoyl anthranilic acids, our initial aim was to further functionalize the free carboxyl group by coupling it with a C-protected α-amino acid, using the mixed carbonic anhydride method. Unexpectedly, the reaction mixture did not yield the anticipated coupling product; instead a new compound was formed, which was subsequently identified as 2-styryl-substituted 4H-benzo[1,3]oxazin-4-one.
Consequently, N-cinnamoyl-anthranilic acids 3a–i and N-piperonyl-anthranilic acid 3j were activated in acetone or 2-methyltetrahydrofuran using 1.5 equivalents of the triethylamine–alkyl chloroformate reagent system at 0 °C for 15 min, as illustrated in Scheme 3.
The 2-styryl-substituted benzo[1,3]oxazin-4-ones 4a–i and 2-(benzo[d][1,3]dioxol-5-yl)-6-methoxy-4H-benzo[d][1,3]oxazin-4-one 4j were synthesized within minutes, providing isolated yields above 90% after a simple ethyl acetate–water work-up. In this transformation, ethyl chloroformate may also be employed as an effective activating reagent. Notably, (E)-2-(3,4-dimethoxystyryl)-4-oxo-4H-benzo[d][1,3]oxazin-6-yl ethyl carbonate 4i, obtained from the 5-hydroxy analogue of Tranilast 3i, was produced in 95% overall yield through two sequential steps starting from 3,4-dimethoxycinnamic acid 1d and 5-hydroxy-2-aminobenzoic acid 2b, without any purification (see Supplementary Materials).
As illustrated for 4b and 4f in Scheme 3, the cyclization proceeds using three equivalents of the alkyl chloroformate/triethylamine reagent system and the corresponding 2-styryl-substituted benzo[1,3]oxazin-4-ones with phenol groups protected as labile carbonates on the anthranilic portion.
Carbonate groups on phenols can be removed within one hour by treatment with an excess of a secondary amine, such as morpholine, in methanol [18]. We therefore employed morpholine both to remove the carbonate protecting group and to induce ring opening of the benzoxazinone, affording the corresponding morpholino amide (Scheme 4).
However, when both transformations were conducted in methanol, the reaction produced not only the expected amide with the free phenolic group but also a significant amount of the corresponding methyl ester. The product distribution confirmed the higher nucleophilicity of the secondary amine compared to a primary alcohol, even when the latter is present in large excess. In contrast, performing both processes in ethyl acetate, without methanol, at room temperature for two hours yielded the amide with the free phenolic function exclusively, in excellent yield (Scheme 4).
Finally, to evaluate the environmental impact of these processes, we compared the preparation of (E)-2-(4-methoxystyryl)-4H-benzo[d][1,3]oxazin-4-one 4d obtained from 3d using the method described here (Scheme 5), with the same compound prepared using procedures reported in the literature [11].
In the literature method, the acyl chloride approach, commonly employed for the acylation of aromatic amino acids in the synthesis of avenanthramides [22], is used in substantial excess. It serves as both the acylation equivalent and the cyclization reagent through anhydride formation. In this case, the % of atom economy (AE), defined as
AE (%) = 100 × Molar mass of product/Molar mass of all reactants
is 52. An even larger excess is required when the aromatic amino acid also contains a phenolic group, as in the case of avenanthramides 3b and 3f. Additionally, the necessary acyl chloride must be prepared using a large excess of SOCl2, a hazardous reagent, and the reaction is typically conducted in toxic pyridine.
These factors make the reaction mixture particularly difficult to purify, ultimately leading to low yields, extensive reagent consumption, and significant chemical waste. In contrast, the method described in this work has an AE (%) = 88, employs a green solvent such as acetone, affords high yields, and generally eliminates the need for chromatographic purification.

3. Materials and Methods

3.1. General Information

Unless otherwise specified, all reactions were carried out using dried solvents. The identities of the products were confirmed by comparing them with literature data whenever possible, using 1H and 13C NMR spectra and HR-MS. The reactions were followed by TLC using silica gel pre-coated aluminum sheets (Macherey Nagel (Düren, Germany): Alugram Xtra SIL GEL UV254 Nr. 818333, thickness 0.2 mm). TLC plates were analyzed under a UV lamp (254 nm). Column chromatography was carried out on silica gel (E. Merck (Darmstadt, Germany), 70–230 mesh). NMR spectra were recorded in CDCl3, (CD3)2SO, or CD3OD on a Bruker Avance 400 (Bruker Corp., Billerica, MA, USA) (400 MHz for 1H, 101 MHz for 13C). For 1H, 13C chemical shifts are presented in δ-scale as ppm (parts per million) with the residual solvent peak as the reference (CDCl3: 7.26 ppm for 1H and 77.23 ppm for 13C; (CD3)2SO: 2.50 ppm for 1H and 39.51 ppm for 13C; CD3OD: 3.31 ppm for 1H and 49.15 ppm for 13C). The description of the multiplicity designations is as follows: s = singlet, d = doublet, dd = doublet of doublets, t = triplet, sept = septet, m = multiplet. MALDI-TOF mass spectrometric analyses were conducted on a Voyager-De Pro MALDI mass-spectrometer (PerSeptive Biosystems, Framingham, MA, USA).

3.2. General Procedure for the Preparation of N-Cinnamoyl-Anthranilic Acids

3.2.1. For Cinnamic Acids Lacking Free Phenolic Groups, Such as 1a, 1c, 1d, and Piperonylic Acid

To a magnetically stirred solution of cinnamic acids (1 mmol) in dry acetone (3 mL), triethylamine (1.1 equivalents, 1.1 mmol, 152 μL) dissolved in dry acetone (2 mL) was added slowly dropwise at room temperature. After a few minutes, the flask containing a clear, light-yellow solution was immersed in an ice bath, and isobutyl chloroformate (1.1 equivalents, 1.1 mmol, 143 μL) dissolved in dry acetone (2 mL) was added dropwise over 15 min. A white precipitate formed, and the mixture was stirred for 20 min at room temperature; at this point, TLC analysis (20% EtOAc in hexane) showed no starting cinnamic acids and a single spot at the front. The mixture was filtered, and the solid was washed with 2 mL of dry acetone.

3.2.2. For Cinnamic Acids with a Single Phenolic Group, Such as 1b and 1e

To a magnetically stirred solution of cinnamic acids (1 mmol) in dry acetone (5 mL), triethylamine (2.2 equivalents, 2.2 mmol, 304 μL) dissolved in dry acetone (5 mL) was added slowly dropwise at room temperature. After a few minutes, the flask containing a clear light-yellow solution was immersed in an ice bath, and isobutyl chloroformate (2.2 equivalents, 2.2 mmol, 286 μL) dissolved in dry acetone (3 mL) was added dropwise over 15 min. A white precipitate formed, and the mixture was stirred for 20 min at room temperature; a TLC control (20% EtOAc in hexane) showed no starting cinnamic acids and a single spot at the top. The mixture was filtered, and the solid was washed with 2 mL of dry acetone.

3.2.3. For Cinnamic Acids with Two Phenolic Groups, Such as Caffeic Acid, 1f

To a magnetically stirred solution of cinnamic acids (1 mmol) in dry acetone (10 mL), a slow dropwise addition of triethylamine (3.3 eq., 3.3 mmol, 458 μL) dissolved in dry acetone (5 mL) was performed at room temperature. After a few minutes, the flask was placed in an ice bath, and isobutyl chloroformate (3.3 eq., 3.3 mmol, 429 μL) dissolved in dry acetone (5 mL) was added dropwise over 15 min. A white precipitate formed, and the mixture was stirred vigorously for 20 min at room temperature. Afterward, TLC analysis (20% EtOAc in Hexane) indicated no starting material and a single spot in the head. The mixture was filtered, and the solid was washed with 5 mL of dry acetone.

3.2.4. Formation of N-Cinnamoyl-Anthranilic Acids

The acetone solution containing the activated and protected cinnamic acids is added dropwise to the solid aromatic amino acid 2a-d, followed by an additional equivalent of triethylamine (1.05 equivalents). The suspension is then stirred at room temperature for 4 h. During this time, the aromatic amino acid fully dissolves, forming a brown-coloured solution. TLC analysis (70% hexane, 30% EtOAc, 1% AcOH, and 1% MeOH) shows that the protected anhydride has completely disappeared, and a new spot appears with an Rf value lower than that of the initial cinnamic acids. The acetone is completely evaporated using a rotavapor. The residue is then dissolved in 50 mL of ethyl ether, and the mixture is vigorously stirred at room temperature for 1 h. After stirring, the mixture is filtered. The resulting solid is washed twice with petroleum ether (2 × 10 mL) and dried under a stream of N2. The solid is usually pure by TLC. If small impurities are present, the solid is crystallized with ethyl acetate and hexane. N-Cinnamoyl-Anthranilic acids 3a–j were obtained in 72–93% yields.

3.2.5. Formation of 2-Styryl-benzo[d][1,3]oxazin-4-ones

To a magnetically stirred solution of N-cinnamoyl-anthranilic acids (1 mmol) in dry acetone (5 mL), slowly add triethylamine (1.5 equivalents, 1.5 mmol, 208 μL), dissolved in dry acetone (2 mL), at room temperature. After a few minutes, immerse the flask containing a clear light-yellow solution in an ice bath. Then, add dropwise over 15 min either isobutyl chloroformate (1.5 equivalents, 1.5 mmol, 195 μL) or ethyl chloroformate (1.5 equivalents, 1.5 mmol, 142 μL), both dissolved in dry acetone (3 mL) (for N-cinnamoyl-anthranilic acids 3b, 3f, and 3i, three equivalents of TEA/alkyl chloroformate reagent system were used). A white precipitate forms, and the mixture is stirred for 30 min at room temperature. At this point, a TLC check (20% EtOAc in hexane) shows no remaining N-cinnamoyl-anthranilic acids and a single spot with a higher Rf. Filter the mixture and wash the solid with 2 mL of acetone. TLC analysis of the filtrate reveals a single spot. Evaporate the filtrate under vacuum, then dissolve the residue in 50 mL of ethyl acetate. Wash this with water (2 × 10 mL), dry over Na2SO4, and evaporate under vacuum again.

3.2.6. Carbonate Deprotection and Ring Opening of Benzo[d][1,3]oxazin-4-ones

Reaction in MeOH
(E)-4-(2-(6,7-Dimethoxy-4-oxo-4H-benzo[d][1,3]oxazin-2-yl)vinyl)phenyl isobutyl carbonate 4g, (212 mg, 0.5 mmol) is dissolved under an N2 atmosphere in 5 mL of MeOH (0.1 M). To this solution, 10 equivalents of morpholine (5 mmol, 435 mg, 433 μL) are added dropwise. The dark brown mixture is stirred for 2 h, during which TLC (70% hexane, 30% EtOAc, 1% AcOH, 2% MeOH) confirms the disappearance of the starting material and the appearance of new spots with lower Rf values. The methanolic solution is evaporated in vacuo. The residue is dissolved in ethyl acetate (50 mL) and treated with a 5% aqueous citric acid solution. The organic phase is separated, washed with water until neutral, dried over Na2SO4, and evaporated in vacuo. The crude reaction product shows two spots on TLC analysis and is chromatographed on silica gel (hexane-ethyl acetate, 10–50%).
Reaction in EtOAc
(E)-Ethyl (4-oxo-2-styryl-4H-benzo[d][1,3]oxazin-6-yl) carbonate 4b, (168 mg, 0.5 mmol), is dissolved under a nitrogen atmosphere in 5 mL of EtOAc (0.1 M). To this solution, 10 equivalents of morpholine (5 mmol, 435 mg, 433 μL) are added dropwise. The dark brown mixture is stirred for 2 h, during which TLC (70% hexane, 30% EtOAc, 1% AcOH, 2% MeOH) confirms the disappearance of the starting material and the appearance of a new single spot with a lower Rf. The reaction mixture is diluted with ethyl acetate (50 mL) and treated with a 5% aqueous citric acid solution. The organic phase is separated, washed with water until neutral, dried over Na2SO4, and evaporated in vacuo.

4. Conclusions

The synthetic methodology described here enables the rapid preparation of two valuable classes of 2-aminobenzoic acid derivatives—namely, substituted N-hydroxycinnamoyl and N-benzoyl-anthranilic acids—as well as the corresponding 4H-benzo[d][1,3]oxazin-4-one, through an environmentally sustainable mixed-anhydride process. These procedures require no metal catalysts, do not rely on external heating, and are carried out in green solvents such as acetone, 2-methyltetrahydrofuran, and ethyl acetate, using the alkyl chloroformate/triethylamine system as both an activating and simultaneous protecting reagent. Unlike acyl chlorides, mixed anhydrides function as “soft” acylating agents, and any free phenolic groups present are protected during the activation step rather than during the coupling reaction. This feature results in crude reaction mixtures that can be purified readily by crystallization, affording the desired products in excellent yields. Furthermore, the methodology provides compounds in protected phenolic forms, which offers practical advantages such as enhanced shelf stability and greater versatility for subsequent synthetic elaboration. Compared to traditional procedures described in the literature, the present approach delivers a markedly improved synthetic route that excels in environmental compatibility, operational simplicity, and economic sustainability. Overall, this green, efficient, and broadly applicable strategy provides a viable and scalable platform for the sustainable synthesis of key molecules required for biochemical research and a variety of anticipated applications in organic and medicinal chemistry.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules31040709/s1, Table S1. 1H, 13C and 2D-NMR data of 3a in (CD3)2SO; Table S2. 1H, 13C and 2D-NMR data of 3b in CDCl3; Table S3. 1H, 13C and 2D-NMR data of 3c in CDCl3; Table S4. 1H, 13C and 2D-NMR data of 3d in (CD3)2SO; Table S5. 1H, 13C and 2D-NMR data of 3e in (CD3)2SO; Table S6. 1H, 13C and 2D-NMR data of 3f in CD3OD; Table S7. 1H, 13C and 2D-NMR data of 3g in CDCl3; Table S8. 1H, 13C and 2D-NMR data of 3h in CDCl3; Table S9. 1H, 13C and 2D-NMR data of 3i in (CD3)2SO; Table S10. 1H, 13C and 2D-NMR data of 3i in (CD3)2SO; Table S11. 1H, 13C and 2D-NMR data of 4a in (CD3)2SO; Table S12. 1H, 13C and 2D-NMR data of 4b in CDCl3; Table S13. 1H, 13C and 2D-NMR data of 4c in CDCl3; Table S14. 1H, 13C and 2D-NMR data of 4d in CDCl3; Table S15. 1H, 13C and 2D-NMR data of 4e in (CD3)2SO; Table S16. 1H, 13C and 2D-NMR data of 4f in (CD3)2SO; Table S17. 1H, 13C and 2D-NMR data of 4g in CDCl3; Table S18. 1H, 13C and 2D-NMR data of 4h in CDCl3; Table S19. 1H, 13C and 2D-NMR data of 4i in CDCl3; Table S20. 1H, 13C and 2D-NMR data of 4i in (CD3)2SO; Table S21. 1H, 13C and 2D-NMR data of 6g in (CD3)2SO; Table S22. 1H, 13C and 2D-NMR data of 5g in (CD3)2SO; Table S23. 1H, 13C and 2D-NMR data of 5b in (CD3)2SO.

Author Contributions

A.Z. and L.L. contributed equally to all aspects of the work, including conceptualization, methodology, software, validation, investigation, resources, data curation, writing—original draft preparation, writing—review and editing, and supervision. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Italian Ministry of University and Research (MUR) under the PRIN 2022 program–D.D. MUR No. 104 dated 2 February 2022–through the project “multi-Risk sciEnce for resilienT commUnities undeR a changiNg climate (RETURN)” (MUR M4-C2-I1.3), Grant ID PE_00000005, CUP Code E63C22002000002.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
DMFDimethylformamide
HCAsHydroxycinnamic acids
iBoc-ClIsobutyl chloroformate
Etoc-ClEthyl Chloroformate

References

  1. Moussa, Z.; Ramanathan, M.; Al-Masri, H.T.; Ahmed, S.A. Recent progress in the synthesis of benzoxazin-4-ones, applications in N-directed ortho-functionalizations, and biological significance. Molecules 2024, 29, 5710. [Google Scholar] [CrossRef]
  2. Von Nussbaum, F.; Li, V.M. Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores. Bioorg. Med. Chem. Lett. 2015, 25, 4370−4381. [Google Scholar] [CrossRef] [PubMed]
  3. Hedstrom, L.; Moorman, A.R.; Dobbs, J.; Abeles, R.H. Suicide inactivation of chymotrypsin by benzoxazinones. Biochemistry 1984, 23, 1753. [Google Scholar] [CrossRef] [PubMed]
  4. Kopelman, P.; Bryson, A.; Hickling, R.; Rissanen, A.; Rossner, S.; Toubro, S.; Valensi, P. Cetilistat (ATL-962), a novel lipase inhibitor: A 12-week randomized, placebo-controlled study of weight reduction in obese patients. Int. J. Obes. 2007, 31, 494–499. [Google Scholar] [CrossRef] [PubMed]
  5. Mohareb, R.M.; Mohamed, A.A.; Ibrahim, R.A. Design, synthesis, molecular docking and biological studies of 4H-Benzo[d][1,3]oxazin-4-one derivatives and their uses in heterocyclic synthesis. ChemistrySelect 2022, 7, e202200325. [Google Scholar] [CrossRef]
  6. Coppola, G. The chemistry of 4H-3,1-benzoxazin-4-ones. J. Heterocycl. Chem. 1999, 36, 563–588. [Google Scholar] [CrossRef]
  7. Khan, S.A.; Yang, H.; Ying, F.; Chu, C.N.; Lee, T.K.W. Polypharmacology-driven discovery of ZAK-I-57: A potent multi-targeted benzoxazinone small molecule for hepatocellular carcinoma therapy. MedComm 2025, 6, e70291. [Google Scholar] [CrossRef]
  8. Kumar, P.; Dutta, S.; Batra, D.; Mishra, D.; Kumar, D.; Bhalla, G.; Singh, B.K. Selective functionalization of 2-phenyl-4H-benzo[d][1,3]oxazin-4-ones via C–H activation. Tetrahedron 2025, 173, 134466. [Google Scholar] [CrossRef]
  9. Kumar, P.; Gupta, M.; Bahadur, V.; Parmar, V.S.; Singh, B.K. Radical-induced, palladium-catalyzed C–H activation: An approach to functionalize 4H-benzo[d][1,3]oxazin-4-one derivatives by using toluenes, aldehydes, and benzyl alcohols. Eur. J. Org. Chem. 2018, 2018, 1552–1558. [Google Scholar] [CrossRef]
  10. Marasini, B.P.; Rahim, F.; Perveen, S.; Karim, A.; Mohammed Khan, K.; Atta-Ur-Rahman, C.M.I. Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors. Bioorg. Chem. 2017, 70, 210–221. [Google Scholar] [CrossRef]
  11. Goel, P.; Jumpertz, T.; Tichá, A.; Ogorek, I.; Mikles, D.C.; Hubalek, M.; Pietrzik, C.U.; Strisovsky, K.; Schmidt, B.; Weggen, S. Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors. Bioorg. Med. Chem. Lett. 2018, 28, 1417–1422. [Google Scholar] [CrossRef]
  12. Gataullin, R.R. Advances in the synthesis of aryl-fused six- to nine-membered N,O-heterocycles. Russ. Chem. Bull. 2025, 74, 585–622. [Google Scholar] [CrossRef]
  13. Yan, J.; Yang, Z.; Guo, J.; Xue, Q.; Chen, P. Efficient synthesis of 2-aryl-4H-benzo[d][1,3]oxazin-4-ones by copper-catalyzed decarboxylation of α-keto acids with anthranilic acids. Asian J. Org. Chem. 2024, 13, e202400157. [Google Scholar] [CrossRef]
  14. Annor-Gyamfi, J.K.; Bunce, R.A. 4H-Benzo[d][1,3]oxazin-4-ones and dihydro analogs from substituted anthranilic acids and ortho-esters. Molecules 2019, 24, 3555. [Google Scholar] [CrossRef] [PubMed]
  15. Wang, H.-X.; Wei, T.-Q.; Xu, P.; Wang, S.-Y.; Ji, S.-J. I2/TBHP-mediated oxidative coupling of amino-based bisnucleophiles and isocyanides: Access to 2-aminobenzoxazinones, 2-aminobenzoxazines, and 2-aminoquinazolies under metal-free conditions. J. Org. Chem. 2018, 83, 13491–13497. [Google Scholar] [CrossRef]
  16. Zheng, Y.; Dong, M.; Qu, E.; Bai, J.; Wu, X.F.; Li, W. Pd-catalyzed carbonylative synthesis of 4H-Benzo[d][1,3]oxazin-4-ones using benzene-1,3,5-triyl triformate as the CO source. Chem. Eur. J. 2021, 27, 16219. [Google Scholar] [CrossRef]
  17. Dhawa, U.; Kaplaneries, N.; Ackermann, L. Green strategies for transition metal-catalyzed C–H activation in molecular syntheses. Org. Chem. Front. 2021, 8, 4886–4913. [Google Scholar] [CrossRef]
  18. Zarrelli, A.; Longobardo, L. Improved chemical synthesis of avenanthramides family and its analogs by mixed anhydride method. Eur. J. Org. Chem. 2025, 28, e202500169. [Google Scholar] [CrossRef]
  19. Petrillo, F.; Maione, A.; Spampinato, M.; Massa, L.D.; Guida, M.; Zarrelli, A.; Galdiero, E.; Longobardo, L. Antifungal and antibiofilm activities of 2-aminobenzoic acid derivatives against a clinical ocular Candida albicans isolate for biomedical applications. Antibiotics 2025, 14, 432. [Google Scholar] [CrossRef]
  20. Longobardo, L.; Di Fabio, G.; Zarrelli, A. Sustainable chemical derivatization of hydroxycinnamic acids. ChemistrySelect 2024, 9, e202305046. [Google Scholar] [CrossRef]
  21. DellaGreca, M.; Longobardo, L. Protection and Activation of Hydroxycinnamic Acids in Water. ChemistrySelect 2020, 5, 4588. [Google Scholar] [CrossRef]
  22. Collins, F.W. Oat phenolics: Avenanthramides, novel substituted N-cinnamoylanthranilate alkaloids from oat groats and hulls. J. Agric. Food Chem. 1989, 37, 60–66. [Google Scholar] [CrossRef]
Figure 1. Representative examples of biologically relevant compounds featuring the benzo[d][1,3]oxazin-4-one heterocyclic core.
Figure 1. Representative examples of biologically relevant compounds featuring the benzo[d][1,3]oxazin-4-one heterocyclic core.
Molecules 31 00709 g001
Scheme 1. 2-Styryl-benzo[d][1,3]oxazin-4-ones from N-cinnamoyl-anthranilic acids.
Scheme 1. 2-Styryl-benzo[d][1,3]oxazin-4-ones from N-cinnamoyl-anthranilic acids.
Molecules 31 00709 sch001
Scheme 2. Preparation of N-cinnamoyl and N-benzoyl-anthranilic acids.
Scheme 2. Preparation of N-cinnamoyl and N-benzoyl-anthranilic acids.
Molecules 31 00709 sch002
Scheme 3. Preparation of benzo[1,3]oxazin-4-ones from N-cinnamoyl anthranilic acids.
Scheme 3. Preparation of benzo[1,3]oxazin-4-ones from N-cinnamoyl anthranilic acids.
Molecules 31 00709 sch003
Scheme 4. Ring opening and deprotection of 4g and 4b with morpholine, in methanol or ethyl acetate.
Scheme 4. Ring opening and deprotection of 4g and 4b with morpholine, in methanol or ethyl acetate.
Molecules 31 00709 sch004
Scheme 5. Comparative preparation of (E)-2-(4-methoxystyryl)-4H-benzo[d][1,3]oxazin-4-one 4d [11].
Scheme 5. Comparative preparation of (E)-2-(4-methoxystyryl)-4H-benzo[d][1,3]oxazin-4-one 4d [11].
Molecules 31 00709 sch005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zarrelli, A.; Longobardo, L. Eco-Friendly Synthesis of 2-Styryl-benzo[d][1,3]oxazin-4-ones from N-Cinnamoyl-Anthranilic Acids. Molecules 2026, 31, 709. https://doi.org/10.3390/molecules31040709

AMA Style

Zarrelli A, Longobardo L. Eco-Friendly Synthesis of 2-Styryl-benzo[d][1,3]oxazin-4-ones from N-Cinnamoyl-Anthranilic Acids. Molecules. 2026; 31(4):709. https://doi.org/10.3390/molecules31040709

Chicago/Turabian Style

Zarrelli, Armando, and Luigi Longobardo. 2026. "Eco-Friendly Synthesis of 2-Styryl-benzo[d][1,3]oxazin-4-ones from N-Cinnamoyl-Anthranilic Acids" Molecules 31, no. 4: 709. https://doi.org/10.3390/molecules31040709

APA Style

Zarrelli, A., & Longobardo, L. (2026). Eco-Friendly Synthesis of 2-Styryl-benzo[d][1,3]oxazin-4-ones from N-Cinnamoyl-Anthranilic Acids. Molecules, 31(4), 709. https://doi.org/10.3390/molecules31040709

Article Metrics

Back to TopTop